Invokana: FDA Warnings on SGLT2 Diabetes Drugs
Sheller, P.C. attorneys are investigating the newer class of diabetes drugs following FDA warnings. ABOUT THE DRUGS Invokana (Invokamet) is a relatively new SGLT2 inhibitor diabetes drug that is intended to be used in combination with diet and exercise to improve glycemic control and lower blood sugar in adults with type 2 diabetes mellitus. When […]
SHELLER IN PHILADELPHIA LIFE
[pdf-embedder url=”/wp-content/uploads/2015/05/1212-Philadelphia-Life_Sheller_profile_FINAL.pdf”]
2015 SUPERLAWYERS
The attorneys at Sheller P.C. have been recognized again this year as SuperLawyers. For the twelfth consecutive year, founder Stephen A. Sheller has been selected by the organization and specifically honored as one of the Top 100 attorneys in both Pennsylvania and Philadelphia. (continues below) In addition to Mr. Sheller’s recognition, attorney Jamie L. Sheller have been awarded […]
OIG Medicare/Medicaid Whistleblower Fraud Alert and WSJ on physician medical device distributorship
The Wall Street Journal 2013-07-26 The Wall Street Journal today published a front page story on the Department of Justice investigation into fraud in physician-owned distributorships of medical devices. Some instances of this type of Medicare/Medicaid fraud is reported by whistleblowers with representation of whistleblower law firms including Sheller, P.C. Healthcare and other professionals who […]
Sheller on Lawyer Spars With FDA Over J&J Risperdal Court Documents
Pharmalot.com, Pharmaceutical Industry News 2013-07-11 In an unusual tactic, an attorney is prodding the FDA to seek documents that purportedly detail side effects caused by the Risperdal antipsychotic, but cannot be released publicly due to a court order. The documents were sealed by a Philadelphia judge as part of ongoing litigation over claims the Johnson […]
Sheller in Philadelphia Inquirer “FDA Slow to Ask J&J for Drug Data”
The Philadelphia Inquirer & “Fierce Pharma” 2013-07-10 The U.S. Food and Drug Administration is dragging its feet in addressing concerns that Johnson & Johnson’s antipsychotic drugs Risperdal and Invega are dangerous, a Philadelphia lawyer says in letters to the federal agency, and the company should allow those alleging harm from the medicines to release information […]
Sheller on American Law Journal TV discussing FDA and Pharma Executives,
The American Law Journal 2013-06-16 Attorney Stephen Sheller sparred with pharmaceutical defense attorney Hope Freiwald of Dechert law firm on the television program The American Law Journal. The attorneys, joined by Pharmalot author Ed Silverman, Atlanta pharmaceutical product liability attorney Matthew Harman in a program moderated by attorney Christopher Naughton discussed the FDA and drug […]
Sheller in Philadelphia Inquirer “High Court Sides with Philadelphia Drug Firm”
2013-06-25 In a case involving a Philadelphia company, a divided U.S. Supreme Court ruled Monday that federal pharmaceutical laws preempt a person’s ability to sue in state court alleging that a generic drug is designed badly and therefore is dangerous. The court’s 5-4 decision in Mutual Pharmaceutical Co. v. Bartlett is a victory for the […]
SuperLawyers 2013: seven Sheller, P.C. attorneys honored
2013-05-17 [pdf-embedder url=”http://sheller.com/wp-content/uploads/2013/05/Sheller_PASLRS13_FINAL.pdf”] The law firm of Sheller, P.C. announces the selection of six attorneys as Pennsylvania SuperLawyers® and one as Pennsylvania Rising Star for 2013. Stephen A. Sheller is once again honored for the tenth straight year, and for the fourth year as a Top 100 Philadelphia and Top 100 Pennsylvania SuperLawyers®. Also for […]
Temple Times on Sheller Center for Social Justice
2013-02-15 [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/Temple_Times_story_Sheller_Center_for_Social_Justice_2_15_13.pdf”] Featured story: “Sheller Family Foundation’s $1.5 million gift to Temple Law will establish Social Justice Center” Stephen and Sandra Sheller, who have spent their respective careers in law and behavioral health treatment advocating for the poor, powerless and those experiencing injustice, have made a $1.5 million gift to establish a new […]
